| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |